You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sodium Glucose Cotransporter 2 (SGLT-2) Inhibitors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type2 Diabetes, Heart Failure With Preserved Ejection Fraction Trial in San Antonio (Empagliflozin 25 MG, Placebo)

Recruiting
  • Type2 Diabetes
  • Heart Failure With Preserved Ejection Fraction
  • Empagliflozin 25 MG
  • Placebo
  • San Antonio, Texas
  • +1 more
Jan 21, 2023

Transthyretin Amyloid Cardiomyopathy Trial in New York (Empagliflozin)

Recruiting
  • Transthyretin Amyloid Cardiomyopathy
  • New York, New York
    Columbia University Irving Medical Center / NewYork-Presbyterian
Mar 15, 2022

(NIS) on Sodium-glucose Co-transporter-2 Inhibitors Use in

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Sodium/glucose cotransporter-2 inhibitors (SGLT2i)
  • (no location specified)
May 22, 2023

Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan

Recruiting
  • Heart Failure
  • +2 more
  • SGLT2 inhibitor
  • Roma, RM, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCSS
Jun 28, 2023

SGLT2 Inhibition in Heart Failure

Recruiting
  • Heart Failure
  • Sodium-glucose cotransporter 2 inhibitor
  • Belfast, United Kingdom
    Belfast Health and Social Care Trust
Nov 15, 2023

Cystinuria Trial in San Francisco (Dapagliflozin)

Recruiting
  • Cystinuria
  • San Francisco, California
    University of California, San Francisco
Oct 4, 2022

SGLT-2 Inhibitors in the Treatment of Ascites

Recruiting
  • Ascites Hepatic
  • +2 more
  • SGLT2 inhibitor
  • Palermo, Italy
  • +1 more
Aug 11, 2023

Diabetes, Cellular Senescence, Sodium-Glucose Transporter 2 Inhibitors Trial in Seoul (SGLT2 inhibitor, Glimepiride)

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • Seoul, Korea, Republic of
    Yonsei University College of Medicine
Aug 1, 2023

Heart Failure Trial in Denmark (Digital letter)

Recruiting
  • Heart Failure
  • Digital letter
  • Copenhagen, Denmark
  • +4 more
Jun 5, 2023

Diabetic Retinopathy Trial in Cairo (Dapagliflozin 10mg Tab plus another oral hypoglycemic agent, Two oral hypoglycemic agents

Recruiting
  • Diabetic Retinopathy
  • Dapagliflozin 10mg Tab plus another oral hypoglycemic agent
  • Two oral hypoglycemic agents other than dapagliflozin
  • Cairo, Egypt
    Internal medicine and endocrinology department, Ain-shams univer
Jun 9, 2022

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • Myocardial Infarction
  • PCI
  • Naples, Italy
    Celestino Sardu
Aug 31, 2023

Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)

Not yet recruiting
  • Fatty Liver, Nonalcoholic
  • SGLT2 inhibitor
  • (no location specified)
Oct 31, 2023

Heart Failure With Reduced Ejection Fraction Trial in Porto (Sacubitril-valsartan, SGLT2 inhibitor)

Recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Porto, Portugal
  • +3 more
Aug 9, 2023

IgA Nephropathy, Immunoglobulin A Nephropathy Trial (Atrasentan, Placebo)

Not yet recruiting
  • IgA Nephropathy
  • Immunoglobulin A Nephropathy
  • (no location specified)
Apr 27, 2023

Called FLAMINgO to Learn More About Treatment Combination of

Active, not recruiting
  • Chronic Kidney Disease
  • Type 2 Diabetes
  • Finerenone (Kerendia, BAY94-8862)
  • Sodium-glucose cotransporter-2 inhibitors (SGLT2i)
  • Whippany, New Jersey
    Bayer
Jan 19, 2023

Acute Kidney Injury, Kidney Failure, Sodium Glucose Cotransporter-2 Inhibitors Trial in Newtown (SGLT2 inhibitor or matched )

Not yet recruiting
  • Acute Kidney Injury
  • +2 more
  • SGLT2 inhibitor or matched placebo
  • Newtown, New South Wales, Australia
    The George Institute for Global Health
Jul 19, 2022

Acute Kidney Injury, Cardiac Surgery, Sodium-Glucose Transporter 2 Inhibitor Trial in Netherlands (Dapagliflozin 10 MG Oral

Not yet recruiting
  • Acute Kidney Injury
  • +2 more
  • Dapagliflozin 10 MG Oral Tablet [Farxiga]
  • Placebo
  • Amsterdam, Netherlands
  • +5 more
Oct 18, 2022

Heart Failure, Diabetes, Type 2 Trial in United States (Dapagliflozin 10 MG, Protocolized Diuretic Therapy)

Recruiting
  • Heart Failure
  • Diabetes Mellitus, Type 2
  • Dapagliflozin 10 MG
  • Protocolized Diuretic Therapy
  • Jackson, Mississippi
  • +5 more
Feb 1, 2022

Sodium Glucose Cotransporter 2 Inhibitiors on Left Ventricular

Not yet recruiting
  • SGLT2 Inhibitiors Remodeling Effect
  • Chronic Heart Disease
  • Sodium-glucose cotransporter 2 inhibitor
  • (no location specified)
Nov 14, 2023

Blood Pressure, Salt; Excess, Diabete Type 2 Trial in Pisa (Hypersodic/Hyposodic diet)

Recruiting
  • Blood Pressure
  • +2 more
  • Hypersodic/Hyposodic diet
  • Pisa, PI, Italy
    Azienda Ospedaliero-Universitaria Pisana
Aug 23, 2023

SGLT2-I in Diabetic AMI (SGLT2-I AMI PROTECT Study)

Recruiting
  • Diabetes Mellitus
  • Acute Coronary Syndrome
    • Aalst, Belgium
    • +6 more
    Mar 2, 2022

    Sodium-glucose Cotransporter 2 Inhibitors Among Type 2 Diabetes

    Completed
    • Diabetes Mellitus, Type 2
    • +3 more
    • Sodium-glucose cotransporter 2 (SGLT2) inhibitors
    • +2 more
    • Montreal, Quebec, Canada
      Lady Davis Institute for Medical Research, Jewish General Hospit
    Aug 17, 2020

    Sodium-glucose Cotransporter 2 Inhibitors and Risk of

    Completed
    • Type2 Diabetes
    • +5 more
    • Sodium-glucose cotransporter 2 (SGLT2) inhibitors
    • Dipeptidyl peptidase-4 (DPP-4) inhibitors
    • Montreal, Quebec, Canada
      Lady Davis Institute for Medical Research, Jewish General Hospit
    Oct 1, 2020

    Fatty Liver Disease Trial (Empagliflozin 10 MG)

    Not yet recruiting
    • Fatty Liver Disease
    • Empagliflozin 10 MG
    • (no location specified)
    Jan 19, 2023

    PCO Trial in Bani Suwayf (Dapagliflozin 5 MG, Metformin Hydrochloride 1000 MG, Dapagliflozin/Metformin)

    Recruiting
    • PCO
    • Dapagliflozin 5 MG
    • +2 more
    • BanÄ« Suwayf, Beni Suef, Egypt
      Beni-suef university
    Oct 26, 2022